Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
"Treatment with beta-blockers remains the standard of care for patients with coronary artery disease, especially when they have had a myocardial infarction [MI; heart attack]. The evidence is derived from relatively old post-MI studies, most of which antedate modern reperfusion or medical therapy, and from heart failure trials, but has been widely extrapolated to patients with CAD and even to patients at high risk for but without established CAD.
It is not known if these extrapolations are justified. Moreover, the long-term efficacy of these agents in patients treated with contemporary medical therapies is not known, even in patients with prior MI."
"We have shown in our study that if you have a heart attack and take beta-blockers for a year, you probably will benefit. But the question is, how long after a heart attack would beta-blockers offer a benefit? The European Union says use these drugs long-term only in patients with heart failure. American guidelines say to keep taking them for at least three years after a heart attack."
"Among patients enrolled in the international REACH registry, beta-blocker use was not associated with a lower event rate of cardiovascular events at 44-month follow-up, even among patients with prior history of MI. Further research is warranted to identify subgroups that benefit from beta-blocker therapy and the optimal duration of beta-blocker therapy."
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
"β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease"
Sripal Bangalore, MD, MHA; Ph. Gabriel Steg, MD; Prakash Deedwania, MD; Kevin Crowley, MS; Kim A. Eagle, MD; Shinya Goto, MD, PhD; E. Magnus Ohman, MD; Christopher P. Cannon, MD; Sidney C. Smith, MD; Uwe Zeymer, MD; Elaine B. Hoffman, PhD; Franz H. Messerli, MD; Deepak L. Bhatt, MD, MPH
JAMA. 2012;308(13):1340-1349. doi:10.1001/jama.2012.1255
Visit our Cardiovascular / Cardiology category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Nordqvist, Christian. "Beta-Blockers Are Not So Great." Medical News Today. MediLexicon, Intl., 3 Oct. 2012. Web.
17 Apr. 2014. <http://www.medicalnewstoday.com/articles/251025>
Nordqvist, C. (2012, October 3). "Beta-Blockers Are Not So Great." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/251025.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.